mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.003 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.005 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |